Top news from MedWatch this week
Monday
Novo Nordisk settles securities lawsuit in Denmark
Snipr Biome chose clinical debut in CRISPR-ready USA
Tuesday
Bioinnovation Institute ramps up ambitions, wants twice as many companies under its wing
Leo Pharma and Roche want to strengthen clinical research in Denmark
Wednesday
Layoffs and restructuring will prepare Leo Pharma for IPO
Bavarian Nordic brings in chief operating officer from GSK Vaccines
Sonova wins Veterans Affairs market shares in December
Novo Nordisk partners with Swiss biotech firm on obesity – zebrafish to unlock new drugs
GN enters partnership to detect cognitive impairment in people with hearing loss
Orphazyme upgrades after careful spending year
Thursday
Overwhelming majority passes new EMA powers
Overwhelming majority passes new EMA powers
WSA merges with its independent retailer
Hearing aid industry association responds to FDA’s proposed OTC regulation
Friday
Hearing firms urge FDA to increase OTC safety requirements
Novo Nordisk launches oral semaglutide in India
Coloplast initiates trial of ostomy leakage product
